DEEP AND DURABLE RESPONSES WITH WEEKLY IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: LONG-TERM FOLLOW-UP OF PATIENTS WHO DID NOT UNDERGO SCT

被引：0
|
作者：
Kumar, S. [1 ]
Berdeja, J. [2 ]
Niesvizky, R. [3 ]
Lonial, S. [4 ]
Laubach, J. [5 ]
Hamadani, M. [6 ]
Stewart, A. K. [7 ]
Hari, P. [8 ]
Roy, V. [9 ]
Vescio, R. [10 ]
Kaufman, J. [11 ]
Berg, D. [12 ]
Liao, E. [12 ]
Rajkumar, V. [1 ]
Richardson, P. [5 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] New York Presbyterian Hosp, Weill Cornell Med Coll, Myeloma Ctr, New York, NY USA
[4] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] West Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV USA
[7] Mayo Clin, Coll Med, Scottsdale, AZ USA
[8] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[9] Mayo Clin, Jacksonville, FL 32224 USA
[10] Samuel Oschin Comprehens Canc Inst, Cedars Sinai Outpatient Canc Ctr, Los Angeles, CA USA
[11] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[12] Millennium Pharmaceut Inc, Cambridge, MA USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S408
引用
收藏
页码：142 / +
页数：2
相关论文
共 50 条
  • [21] Impact of dexamethasone responsiveness on long-term outcome in patients with newly diagnosed myeloma
    Sinha, S.
    Rajkumar, S. V.
    Lacy, M.
    Hayman, S.
    Baudi, F.
    Dispenzieri, A.
    Lust, J.
    Greipp, P.
    Gertz, M.
    Kumar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Lenalidomide Induction and Maintenance Maximizes Outcome for Newly Diagnosed Transplant Eligible Myeloma Patients Irrespective of Risk Status: Long-Term Follow-up of the Myeloma XI Trial
    Jackson, Graham
    Pawlyn, Charlotte
    Cairns, David
    Jones, John R.
    Kishore, Bhuvan
    Garg, Mamta
    Williams, Cathy
    Karunanithi, Kamaraj
    Lindsay, Jindriska
    Russell, Nigel H.
    Jenner, Matthew
    Cook, Gordon
    Drayson, Mark T.
    Owen, Roger G.
    Gregory, Walter M.
    Kaiser, Martin F.
    Davies, Faith E.
    Morgan, Gareth
    BLOOD, 2019, 134
  • [23] Long-term follow-up of intensive therapy (IT) for patients (pts) with newly diagnosed multiple myeloma (MM). A single center experience.
    Harousseau, JL
    Moreau, P
    Milpied, N
    BONE MARROW TRANSPLANTATION, 1998, 21 : S204 - S204
  • [24] Impact of dexamethasone responsiveness on long term outcome in patients with newly diagnosed multiple myeloma
    Sinha, Shirshendu
    Rajkumar, S. Vincent
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Dispenzieri, Angela
    Dingli, David
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (06) : 853 - 858
  • [25] LENALIDOMIDE LONG-TERM NEUROTOXICITY: NEUROPHYSIOLOGICAL FOLLOW-UP STUDY IN PATIENTS WITH RELAPSED/REFRACTORY MYELOMA
    Dalla Torre, C.
    Cacciavillani, M.
    Campagnolo, M.
    Lucchetta, M.
    Bemo, T.
    De March, E.
    Zambello, R.
    Briani, C.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 122 - 122
  • [26] Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma
    Reeder, Craig B.
    Reece, Donna E.
    Kukreti, Vishal
    Mikhael, Joseph R.
    Chen, Christine
    Trudel, Suzanne
    Laumann, Kristina
    Vohra, Harjot
    Fonseca, Rafael
    Bergsagel, P. Leif
    Leis, Jose F.
    Tiedemann, Rodger
    Stewart, A. Keith
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (04) : 563 - 565
  • [27] Long-term follow-up of a comparison of nonmyeloablative allografting with autografting for newly diagnosed myeloma
    Giaccone, Luisa
    Storer, Barry
    Patriarca, Francesca
    Rotta, Marcello
    Sorasio, Roberto
    Allione, Bernardino
    Carnevale-Schianca, Fabrizio
    Festuccia, Moreno
    Brunello, Lucia
    Omede, Paola
    Bringhen, Sara
    Aglietta, Massimo
    Levis, Alessandro
    Mordini, Nicola
    Gallamini, Andrea
    Fanin, Renato
    Massaia, Massimo
    Palumbo, Antonio
    Ciccone, Giovannino
    Storb, Rainer
    Gooley, Ted A.
    Boccadoro, Mario
    Bruno, Benedetto
    BLOOD, 2011, 117 (24) : 6721 - 6727
  • [28] Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone
    Vogl, Dan T.
    Delforge, Michel
    Song, Kevin
    Guo, Shien
    Gibson, Craig J.
    Ervin-Haynese, Annette
    Facon, Thierry
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 398 - 405
  • [29] Long-Term Follow-up of Patients With Multiple Myeloma Who Received Allogeneic Hematopoietic Stem Cell Transplantation
    Donato, Michele L.
    Siegel, David S.
    Vesole, David H.
    McKiernan, Phyllis
    Nyirenda, Themba
    Baker, Melissa
    Mato, Anthony
    Richter, Joshua R.
    Pecora, Andrew L.
    Rowley, Scott D.
    BLOOD, 2013, 122 (21)
  • [30] Long-term follow-up of patients treated with bortezomib alone and in combination with dexamethasone as frontline therapy for multiple myeloma.
    Jagannath, Sundar
    Durie, Brian G. M.
    Wolf, Jeffrey Lee
    Camacho, Elber S.
    Irwin, David
    Lutzky, Jose
    McKinley, Marti
    Gabayan, Afshin Eli
    Mazumder, Amitabha
    Crowley, John
    Vescio, Robert
    BLOOD, 2006, 108 (11) : 238A - 239A
12345